Zacks Investment Research on MSN
Abbott Laboratories (ABT) is a trending stock: Facts to know before betting on it
Abbott (ABT) has recently been on Zacks.com's list of the most searched stocks. Therefore, you might want to consider some of the key factors that could influence the stock's performance in the near ...
Abbott (ABT) ended the recent trading session at $114.12, demonstrating a -1.92% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.04%. Meanwhile, the Dow ...
The stock's fall snapped a three-day winning streak.
Hosted on MSN
Abbott stock is on pace for worst day since 2000. The nutrition business is a drag on earnings.
Shares of Abbott Laboratories sank on Thursday after the medical device maker posted fourth-quarter earnings and sales that underwhelmed Wall Street. For the fourth quarter, Abbott reported adjusted ...
Abbott Laboratories is delivering double-digit percentage earnings growth along with a dependable dividend.
Abbott ABT has consistently demonstrated strong growth and gained market share within its Nutrition business. Its Diabetes Care business continues to benefit from the growing sales of its flagship, ...
Abbott Laboratories (NYSE: ABT) will release its fiscal fourth-quarter earnings report next Thursday before the opening bell, setting up an intriguing idea for bullish options traders. Ordinarily, ABT ...
Abbott is an innovator and has made plenty of highly successful breakthroughs. That's what it did with its FreeStyle Libre ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results